New drug ISH0613 takes first step: safety check in healthy volunteers
NCT ID NCT07516639
First seen Apr 10, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This early-stage study tests a new drug, ISH0613, in 26 healthy adults to see if it is safe and how the body processes it. Participants get one dose of the drug or a placebo and are closely monitored for side effects. This research is a first step before testing the drug in people with lupus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE (SYSTEMIC LUPUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Drum Tower Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, 210000, China
Conditions
Explore the condition pages connected to this study.